Monographs / COPD Updates: Pharmaceutical Benefits Advisory Committee Recommendations about Inhaled Medications


expert
Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals
This article discusses the updated recommendations for use of inhaled medications in patients with chronic obstructive pulmonary disease, effective 1 August 2018.
Written by Dr Philip Lee BScMed MBBS (Hons) UNSW FRACP
Dr Philip Lee is a consultant in Respiratory and Sleep Medicine at St George Hospital. He has received local and international awards for his research work with continuing clinical and research interests in COPD, respiratory failure, non-invasive ventilation and sleep medicine. He is an expert advisor for Research Review Australia in COPD and has been an invited speaker at various local meetings. In 2016, Dr Lee received the St George Individual Volunteer Achievement Award for his outstanding contribution to the community.

Rosacea – Smarter Diagnosis and State of the Art Care

The Role of SGLT2 Inhibitors in Preventing Dialysis

Syphilis is on the Rise – What GPs Can do to Turn it Around

COPD Cases

expert
Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals



It should only change if there's clear evidence that a new model is better
It should remain independent and locally governed
It should be replaced with an untested national model
Listen to expert interviews.
Click to open in a new tab
Browse the latest monographs from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.